Omkar Speciality Chemicals Board of Directors

Get the latest insights into the leadership at Omkar Speciality Chemicals. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Pravin S Herlekar Chairman & Managing Director
Mr. Subhash Ambatkar Executive Director
Mrs. Sanjivani S Patare Independent Director
Ms. Archana Dakhale Independent Director
Mr. Kannan Thevar Non Exe.Non Ind.Director

Omkar Speciality Chemicals Share price

OMKARCHEM

5.98

0.28 (-4.47%)
NSE
BSE
Last updated on 29 Aug, 2025 | 15:17 IST
BUYSELL
Today's High

6.55

Today's Low

5.94

52 Week Low

5.01

52 Week High

11.39

The current prices are delayed, login to your account for live prices

Omkar Speciality Chemicals FAQs

The board at Omkar Speciality Chemicals consists of experienced professionals, including Mr. Pravin S Herlekar , Mr. Subhash Ambatkar , and others, overseeing the company’s strategic and corporate governance.

Directors at Omkar Speciality Chemicals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Pravin S Herlekar is the current chairman at Omkar Speciality Chemicals.

Executive directors at Omkar Speciality Chemicals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Omkar Speciality Chemicals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Omkar Speciality Chemicals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.